Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $369.86 | 12 | 88.8% |
| Education | $46.60 | 1 | 11.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $176.61 | 7 | $0 (2023) |
| Medtronic MiniMed, Inc. | $136.61 | 2 | $0 (2019) |
| Abbott Laboratories | $84.90 | 3 | $0 (2024) |
| Medtronic, Inc. | $18.34 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.44 | 1 | Abbott Laboratories ($21.44) |
| 2023 | $16.57 | 1 | Novo Nordisk Inc ($16.57) |
| 2022 | $75.64 | 4 | Novo Nordisk Inc ($75.64) |
| 2021 | $102.74 | 3 | Novo Nordisk Inc ($84.40) |
| 2019 | $64.44 | 1 | Medtronic MiniMed, Inc. ($64.44) |
| 2018 | $135.63 | 3 | Medtronic MiniMed, Inc. ($72.17) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes Care | ||||||
| 01/19/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Diabetes | ||||||
| 08/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes | ||||||
| 03/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diabetes | ||||||
| 12/03/2021 | Medtronic, Inc. | Minimed 770G System (Device) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Durable Pump | ||||||
| 10/28/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $73.15 | General |
| Category: Diabetes | ||||||
| 10/27/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Diabetes | ||||||
| 03/28/2019 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $64.44 | General |
| Category: Durable Pump | ||||||
| 11/03/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $72.17 | General |
| Category: Durable Pump | ||||||
| 05/31/2018 | Abbott Laboratories | FreeStyle Freedom Lite system (Device), FreeStyle InsuLinx system, FreeStyle Lite system | Education | In-kind items and services | $46.60 | General |
| Category: Diabetes Care | ||||||
| 03/11/2018 | Abbott Laboratories | FreeStyle Libre Pro (Device) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 366 | 694 | $185,389 | $51,488 |
| 2022 | 4 | 411 | 762 | $198,996 | $59,168 |
| 2021 | 6 | 437 | 709 | $180,304 | $57,786 |
| 2020 | 6 | 454 | 601 | $153,154 | $43,309 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 542 | $161,516 | $45,391 | 28.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 51 | 111 | $12,543 | $2,929 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $5,472 | $1,614 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 29 | $5,858 | $1,554 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 284 | 567 | $159,750 | $49,329 | 30.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $20,889 | $5,493 | 26.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 52 | 115 | $12,293 | $2,793 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 32 | $6,064 | $1,553 | 25.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 233 | 442 | $121,108 | $41,225 | 34.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 62 | 62 | $25,978 | $6,345 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 87 | $16,182 | $5,119 | 31.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 36 | 76 | $7,904 | $2,189 | 27.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 21 | 27 | $5,022 | $1,525 | 30.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 14 | 15 | $4,110 | $1,384 | 33.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 148 | 249 | $68,226 | $18,304 | 26.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 94 | 94 | $39,386 | $11,356 | 28.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 132 | 163 | $30,318 | $8,861 | 29.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 53 | 64 | $11,904 | $3,886 | 32.6% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 16 | 19 | $1,976 | $508.38 | 25.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 11 | 12 | $1,344 | $394.64 | 29.4% |
About Dr. Deval Bhatt, M.D
Dr. Deval Bhatt, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Dublin, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/07/2013. The National Provider Identifier (NPI) number assigned to this provider is 1326385659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deval Bhatt, M.D has received a total of $416.46 in payments from pharmaceutical and medical device companies, with $21.44 received in 2024. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($369.86).
As a Medicare-enrolled provider, Bhatt has provided services to 1,668 Medicare beneficiaries, totaling 2,766 services with total Medicare billing of $211,751. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Dublin, CA
- Active Since 01/07/2013
- Last Updated 07/03/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326385659
Products in Payments
- Minimed 670G System (Device) $136.61
- RYBELSUS (Drug) $84.40
- Ozempic (Drug) $51.72
- FreeStyle Freedom Lite system (Device) $46.60
- Rybelsus (Drug) $40.49
- FREESTYLE LIBRE 3 (Device) $21.44
- Minimed 770G System (Device) $18.34
- FreeStyle Libre Pro (Device) $16.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Dublin
Dr. Jennifer Rittenberry, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $259,875
Pallavy Reddy, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $38,816
Dr. John Stafford, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,364
Taylor Cater, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $318.60
Traci Tupper, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $244.56
Dr. Aruna Chakravorty, M.d., Phd, M.D., PHD
Endocrinology, Diabetes & Metabolism — Payments: $175.79